54 related articles for article (PubMed ID: 16546858)
1. Efficacy of systemic therapy in advanced pancreatic carcinoma.
Lideståhl A; Permert J; Linder S; Bylund H; Edsborg N; Lind P
Acta Oncol; 2006; 45(2):136-43. PubMed ID: 16546858
[TBL] [Abstract][Full Text] [Related]
2. A review of systemic therapy for advanced pancreatic cancer.
El-Rayes BF; Philip PA
Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Locally advanced pancreatic cancer: current therapeutic approach.
Cardenes HR; Chiorean EG; Dewitt J; Schmidt M; Loehrer P
Oncologist; 2006 Jun; 11(6):612-23. PubMed ID: 16794240
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cancer: from molecular signature to target therapy.
Longo R; Cacciamani F; Naso G; Gasparini G
Crit Rev Oncol Hematol; 2008 Dec; 68(3):197-211. PubMed ID: 18436450
[TBL] [Abstract][Full Text] [Related]
6. [Modern systemic therapy of advanced pancreatic cancer: impact on overall survival and medico economical aspects].
Mazzuri S; Roth A
Rev Med Suisse; 2005 Jun; 1(24):1616-20. PubMed ID: 16028707
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer: progress in cancer therapy.
Pierantoni C; Pagliacci A; Scartozzi M; Berardi R; Bianconi M; Cascinu S
Crit Rev Oncol Hematol; 2008 Jul; 67(1):27-38. PubMed ID: 18356073
[TBL] [Abstract][Full Text] [Related]
8. The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure.
Ducreux M; Boige V; Goéré D; Deutsch E; Ezra P; Elias D; Malka D
Best Pract Res Clin Gastroenterol; 2007; 21(6):997-1014. PubMed ID: 18070700
[TBL] [Abstract][Full Text] [Related]
9. Sequential, alternating, and maintenance/consolidation chemotherapy in advanced non-small cell lung cancer: a review of the literature.
Grossi F; Aita M; Follador A; Defferrari C; Brianti A; Sinaccio G; Belvedere O
Oncologist; 2007 Apr; 12(4):451-64. PubMed ID: 17470688
[TBL] [Abstract][Full Text] [Related]
10. Advances in the treatment of patients with gastric adenocarcinoma.
Foukakis T; Lundell L; Gubanski M; Lind PA
Acta Oncol; 2007; 46(3):277-85. PubMed ID: 17450463
[TBL] [Abstract][Full Text] [Related]
11. [Problems of antineoplastic chemotherapy of pancreatic cancer].
Matthias M; Wolff H
Zentralbl Chir; 1987; 112(21):1322-36. PubMed ID: 3324556
[TBL] [Abstract][Full Text] [Related]
12. Drugs in preclinical and early-stage clinical development for pancreatic cancer.
Asuthkar S; Rao JS; Gondi CS
Expert Opin Investig Drugs; 2012 Feb; 21(2):143-52. PubMed ID: 22217246
[TBL] [Abstract][Full Text] [Related]
13. Gastric cancer: standards for the 21st century.
Archie V; Kauh J; Jones DV; Cruz V; Karpeh MS; Thomas CR
Crit Rev Oncol Hematol; 2006 Feb; 57(2):123-31. PubMed ID: 16412659
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials referral resource. Current phase II and phase III clinical trials for pancreatic cancer.
Mooney MM; Schoenfeldt M
Oncology (Williston Park); 2004 Jul; 18(8):1008, 1013-4, 1016. PubMed ID: 15328895
[No Abstract] [Full Text] [Related]
15. Treatment for pancreatic cancer: current therapy and continued progress.
Lockhart AC; Rothenberg ML; Berlin JD
Gastroenterology; 2005 May; 128(6):1642-54. PubMed ID: 15887156
[TBL] [Abstract][Full Text] [Related]
16. The medical management of pancreatic cancer: a review.
McKenna S; Eatock M
Oncologist; 2003; 8(2):149-60. PubMed ID: 12697940
[TBL] [Abstract][Full Text] [Related]
17. Advancements in Systemic Therapy for Pancreatic Cancer.
Brown TJ; Reiss KA; O'Hara MH
Am Soc Clin Oncol Educ Book; 2023 May; 43():e397082. PubMed ID: 37192430
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer in young adults: changes, challenges, and solutions.
Primavesi F; Stättner S; Schlick K; Kiesslich T; Mayr C; Klieser E; Urbas R; Neureiter D
Onco Targets Ther; 2019; 12():3387-3400. PubMed ID: 31118690
[TBL] [Abstract][Full Text] [Related]
19. Systemic Therapy of Pancreatic Cancer: Better Science, Faster Progress.
Philip PA
Oncology (Williston Park); 2015 Nov; 29(11):821, 826. PubMed ID: 26573061
[No Abstract] [Full Text] [Related]
20. Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system.
Yu WD; Ma Y; Flynn G; Muindi JR; Kong RX; Trump DL; Johnson CS
Cell Cycle; 2010 Aug; 9(15):3022-9. PubMed ID: 20699664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]